AAPI Global Health Summit 2026 to Feature Advanced Resuscitation Training

The AAPI Global Health Summit 2026 in Odisha highlighted innovative emergency care training, including mass CPR sessions and AI-driven clinical education, aimed at enhancing India’s emergency medical response.

The American Association of Physicians of Indian Origin (AAPI) is advancing its mission to strengthen global emergency care through innovation, technology, and Indo-U.S. collaboration. A landmark Resuscitation and Emergency Medical Care Workshop was held on January 10, 2026, at the Kalinga Institute of Medical Sciences (KIMS) in Odisha.

This workshop, a signature component of the AAPI Global Health Summit (GHS) 2026, featured mass CPR training on January 9 and high-fidelity simulation alongside AI-enabled multi-specialty clinical case discussions on January 10. These sessions set a new national benchmark for emergency medicine education.

AAPI President Dr. Amit Chakrabarty described the summit as a defining moment for Indo-U.S. medical collaboration. “GHS 2026 reflects AAPI’s unwavering commitment to elevating global health standards,” he stated. “When experts from two of the world’s most dynamic healthcare systems come together, the impact extends far beyond conference halls—it reaches communities, hospitals, and future generations.”

The day began with an ambitious AAPI Mass CPR Training Event for college students, coordinated by Dr. Dillip Panda, Director of KIMS, and Dr. Sathya Swaroop Patnaik of the Sri Sathya Sai Seva Organizations, Odisha. Under the guidance of Dr. Vemuri S. Murthy, a globally recognized Indo-U.S. resuscitation expert and Coordinator of the GHS CME programs, the session trained approximately 1,000 college students in accordance with the latest Resuscitation Guidelines, emphasizing high-quality CPR, early defibrillation, and post-cardiac arrest care.

Dr. Murthy highlighted the importance of early training, stating, “The future of global medical practice lies in the hands of the younger generation—medical students and residents—who have a unique opportunity to integrate cutting-edge technologies such as simulation and AI with traditional clinical evaluation.”

Later in the day, the workshop featured a series of high-impact expert presentations. Dr. Joginder Solanki, representing the American Heart Association, outlined the updated 2025 resuscitation guidelines. Dr. Srinivas Ramaka, a distinguished cardiac arrest research expert in India, delivered a data-rich session on the epidemiology of out-of-hospital cardiac arrest (OHCA) in India, emphasizing the urgent need for public CPR training, improved access to automated external defibrillators (AEDs), and structured emergency response systems.

Dr. Debasish Swain, a faculty member of the National Emergency Life Support (NELS) Program in Odisha, presented the Government of India’s ambitious NELS Program. This mandatory five-day emergency care training initiative for all medical graduates integrates Basic Life Support (BLS), Advanced Cardiac Life Support (ACLS), and Advanced Trauma Life Support (ATLS), with a strong emphasis on hands-on learning.

The simulation and AI-based clinical case discussion workshop featured a distinguished panel of Indo-U.S. faculty, bringing together respected leaders in resuscitation science, emergency medicine, cardiology, and critical care. The expert team, led by Dr. Vemuri Murthy and Dr. Atasu Nayak, Co-Chair of the Workshop, included Dr. Anjali Gulati, Dr. Srinivas Ramaka, Dr. Ashok Kumar Badamali, Dr. Suresh Karne, Dr. Lt. Col. Y. Ashok, Dr. Abanibhusan Jena, Dr. Basanta Mohapatra, Dr. Arun Panigrahi, and Dr. Abhishek Kashyap.

Their combined expertise, spanning cardiology, anesthesiology, critical care, emergency life support, and advanced simulation training, added exceptional depth and credibility to the program, reinforcing the workshop’s status as one of the most comprehensive and high-impact sessions of the summit.

A major highlight of the workshop was the hands-on simulation training featuring the SimMan 3G Plus, an advanced high-fidelity simulation platform provided by Laerdal India. Participants practiced real-time decision-making in complex emergency scenarios, bridging the gap between theoretical knowledge and clinical readiness.

The session also included an AI-based multi-specialty clinical case discussion, showcasing the growing role of artificial intelligence in diagnostic reasoning, triage, and emergency decision support. Dr. Murthy emphasized the significance of these innovations, stating, “Simulation and AI are no longer optional—they are essential tools for improving survival outcomes and elevating the standard of emergency care worldwide.”

The workshop took place against the backdrop of India’s disproportionate burden of cardiovascular disease and trauma. India accounts for 60% of global heart disease patients, and nearly 20 million annual deaths worldwide are attributed to heart-related disorders. Alarmingly, half of all heart attacks in Indians occur before the age of 50, while India records 1.6 million strokes annually, with one-third resulting in disability. Additionally, the country has one of the highest global rates of trauma and head injury, largely due to road accidents.

AAPI has long championed initiatives to address these challenges. Dr. Meher Medavaram, AAPI President-Elect, highlighted the organization’s commitment: “AAPI has been at the forefront of collaborating with Indo-U.S. organizations and training hundreds of first responders at Global Health Summits. These efforts will save lives and strengthen India’s emergency response capacity.”

These trainings equip police, traffic personnel, and paramedics with essential lifesaving skills, significantly improving survival chances in trauma and cardiac emergencies.

The Resuscitation and Emergency Medical Care Workshop was part of a larger summit that showcased groundbreaking advances in clinical practice and medical technology. GHS 2026 featured live robotic and minimally invasive surgeries broadcast between KIMS and Swosti Premium, as well as scientific sessions on metabolic syndrome, hemoglobinopathies, cervical cancer prevention, PSA screening, carotid stenosis, and joint preservation. The summit also facilitated cross-border collaboration between leading Indian and U.S. physicians.

Dr. Amit Chakrabarty remarked, “The integration of advanced technology and international expertise is shaping a new era in Indian healthcare. Odisha is emerging as a hub for clinical excellence and innovation.”

The Resuscitation and Emergency Medical Care Workshop at GHS 2026 reaffirmed AAPI’s leadership in strengthening India’s emergency response infrastructure, promoting Indo-U.S. collaboration in medical education, leveraging simulation and AI to elevate clinical training, and empowering students, residents, and first responders with lifesaving skills.

By uniting innovation, expertise, and a commitment to public health, AAPI continues to drive transformative change, advancing its mission to improve global health outcomes and positioning Odisha as a rising center of excellence in emergency medicine.

For more information on AAPI and its global initiatives, please visit www.appiusa.org.

WHO Advocates Higher Taxes on Sugary Drinks and Alcohol to Combat Diabetes

Increasing taxes on sugary drinks and alcohol is crucial to combat rising non-communicable diseases, according to the World Health Organization.

NEW DELHI – The World Health Organization (WHO) has emphasized the urgent need to increase taxes on fruit juices, sugary drinks, and alcoholic beverages to address the growing prevalence of non-communicable diseases, including obesity, diabetes, heart disease, and certain cancers, particularly among children and young adults.

In two recent global reports, the WHO highlighted that the affordability of sugary drinks and alcohol has been bolstered by consistently low tax rates in many countries. While over 100 nations impose taxes on sugary beverages like sodas, other high-sugar products, including 100 percent fruit juices, sweetened milk drinks, and ready-to-drink coffees and teas, often evade taxation. The median tax on sugary sodas is a mere 2 percent of their retail price.

Moreover, few countries are adjusting these taxes for inflation, which allows these health-harming products to remain increasingly affordable. The WHO noted that the low cost of these beverages contributes to substantial profits for manufacturers, while health systems worldwide are strained under the financial burden of preventable non-communicable diseases and injuries.

“Health taxes are one of the strongest tools we have for promoting health and preventing disease,” stated Dr. Tedros Adhanom Ghebreyesus, WHO Director-General. He further explained that by increasing taxes on products such as tobacco, sugary drinks, and alcohol, governments can reduce harmful consumption and generate funds for essential health services.

In a separate analysis, the WHO reported that the price of alcohol has either decreased or remained stable in most countries since 2022, despite the known health risks associated with its consumption. Currently, at least 167 countries impose taxes on alcoholic beverages, while 12 countries have implemented total bans on alcohol.

However, the WHO found that tax rates on alcohol remain low across various regions, with global median excise tax shares of 14 percent for beer and 22.5 percent for spirits. “More affordable alcohol drives violence, injuries, and disease,” warned Dr. Etienne Krug, Director of WHO’s Department of Health Determinants, Promotion, and Prevention.

Dr. Krug added, “While industry profits, the public often bears the health consequences, and society faces the economic costs.”

The WHO is urging countries to raise and redesign taxes on tobacco, alcohol, and sugary drinks, aiming to increase their real prices by 2035. This strategy is intended to make these products less affordable over time, thereby protecting public health.

According to IANS, the WHO’s recommendations underscore the importance of fiscal policies in addressing health challenges associated with non-communicable diseases.

Health Tech Innovations Highlighted at CES 2026

Innovations showcased at CES 2026 are transforming health technology, featuring AI-driven devices aimed at enhancing wellness, mobility, and safety.

The Consumer Electronics Show (CES) 2026 is currently taking place in Las Vegas, showcasing the latest advancements in consumer technology. This annual event, which spans four days every January, attracts tech companies, startups, researchers, investors, and journalists from around the globe. CES serves as a preview for products that could soon find their way into homes, hospitals, gyms, and workplaces.

This year, while flashy gadgets and robots capture attention, health technology is at the forefront, with a focus on prevention, recovery, mobility, and long-term well-being. Here are some standout health tech products that have garnered significant interest at CES 2026.

NuraLogix has introduced a groundbreaking smart mirror that transforms a brief selfie video into a comprehensive overview of an individual’s long-term health. The Longevity Mirror uses artificial intelligence to analyze subtle blood flow patterns in the user’s face, providing scores for metabolic health, heart health, and physiological age on a scale from zero to 100. Results are delivered in approximately 30 seconds, accompanied by clear explanations and recommendations. The AI system has been trained on hundreds of thousands of patient records, allowing it to convert raw data into understandable insights. The mirror supports up to six user profiles and is set to launch in early 2026 for $899, which includes a one-year subscription. Subsequent annual subscriptions will cost $99, with optional concierge support available to connect users with nutrition and wellness experts.

Ascentiz showcased its H1 Pro walking exoskeleton, which emphasizes real-world mobility applications. This lightweight, modular device is designed to reduce strain while providing motor-assisted movement over longer distances. The system employs AI to adapt assistance based on the user’s motion and terrain, making it effective on inclines and uneven surfaces. Its compact design features a belt-based attachment system, and its dust- and water-resistant construction allows for outdoor use in various conditions. Ascentiz also offers more powerful models, including Ultra and knee or hip-attached versions, demonstrating the shift of exoskeletons from clinical rehabilitation to everyday mobility support.

Cosmo Robotics received a CES Innovation Award for its Bambini Kids exoskeleton, the first overground pediatric exoskeleton with powered ankle motion. Designed for children aged 2.5 to 7 with congenital or acquired neurological disorders, this system offers both active and passive gait training modes. By encouraging guided and natural movement, it helps children relearn walking skills while minimizing complications associated with conditions like cerebral palsy.

For those who spend significant time indoors, the Sunbooster device offers a practical solution for replacing the benefits of natural sunlight. This innovative product clips onto a monitor, laptop, or tablet, projecting near-infrared light while users work, without causing noise or disruption. Near-infrared light, a natural component of sunlight, is associated with improved energy levels, mood, and skin health. Sunbooster utilizes patented SunLED technology to deliver controlled exposure and tracks daily dosage, encouraging two to four hours of use during screen time. The technology has been validated through human and laboratory studies conducted at the University of Groningen and Maastricht University, providing scientific support for its claims. The company is also developing a phone case and a monitor with built-in near-infrared lighting to further enhance indoor sunlight replacement.

Allergen Alert addresses the challenges of dining out with food allergies. This handheld device tests small food samples inside a sealed, single-use pouch, detecting allergens or gluten in meals within minutes. Built on laboratory-grade technology derived from bioMérieux expertise, the system automates the analytical process, delivering results without requiring technical knowledge. Allergen Alert aims to restore confidence and inclusion at the dining table, with plans for pre-orders at the end of 2026 and future expansions to test additional common allergens.

Samsung previewed its Brain Health feature for Galaxy wearables, a research-driven tool that analyzes walking patterns, voice changes, and sleep data to identify potential early signs of cognitive decline. This system leverages data from devices like the Galaxy Watch and Galaxy Ring to establish a personal baseline, monitoring for subtle deviations linked to early dementia. Samsung emphasizes that Brain Health is not intended to diagnose medical conditions but rather to provide early warnings that encourage users and their families to seek professional evaluations sooner. While a public release date has not been confirmed, CES 2026 attendees can experience an in-person demo of the feature.

Withings is redefining the capabilities of bathroom scales with its BodyScan 2, which has earned a CES 2026 Innovation Award. In less than 90 seconds, this smart scale measures ECG data, arterial stiffness, metabolic efficiency, and hypertension risk. The connected app allows users to observe how factors like stress, sedentary habits, menopause, or weight changes impact their cardiometabolic health, shifting the focus from weight alone to early health indicators that can be tracked over time.

Garmin received a CES Innovation Honoree Award for its Venu 4 smartwatch, which features a new health status indicator that highlights when metrics such as heart rate variability and respiration deviate from personal baselines. The watch also includes lifestyle logging, linking daily habits to sleep and stress outcomes, and boasts up to 12 days of battery life for continuous tracking without nightly charging.

Ring introduced Fire Watch, an opt-in feature that utilizes AI to detect smoke and flames from compatible cameras. During wildfires, users can share snapshots with Watch Duty, a nonprofit organization that distributes real-time fire alerts to communities and authorities, demonstrating how existing home technology can enhance public safety during environmental emergencies.

Finally, the RheoFit A1 may be the most relaxing health gadget at CES 2026. This AI-powered robotic roller glides beneath the user’s body to deliver a full-body massage in about 10 minutes. With interchangeable massage attachments and activity-specific programs, it targets soreness from workouts or long hours spent at a desk. The companion app employs an AI body scan to automatically adjust pressure and focus areas.

CES 2026 highlights the evolution of health technology, making it more practical and personal. Many showcased products prioritize early problem detection, stress reduction, and informed health decision-making. As technology becomes increasingly integrated into daily life, these innovations promise to enhance safety and well-being.

Which of these health tech products from CES 2026 would you find most useful in your daily life? Share your thoughts with us at Cyberguy.com.

According to CyberGuy.com.

CDC Revises Stance on Vaccines and Autism After Years of Debate

The CDC has revised its position on the potential link between vaccines and autism, acknowledging that previous claims lacked evidence and prompting a comprehensive assessment of autism causes.

The Centers for Disease Control and Prevention (CDC) has quietly updated its website regarding the controversial link between vaccines and autism. This change follows a comprehensive assessment initiated by the U.S. Department of Health and Human Services (HHS) to explore potential causes of autism.

The revised wording on the CDC’s site now states, “The claim ‘vaccines do not cause autism’ is not an evidence-based claim because studies have not ruled out the possibility that infant vaccines cause autism.” This marks a significant shift from the agency’s previous stance, which asserted that studies had shown no link between vaccinations and the development of autism spectrum disorder (ASD).

The CDC acknowledged that the statement asserting vaccines do not cause autism has been “historically disseminated” by federal health agencies to combat vaccine hesitancy. The agency’s earlier position was more definitive, claiming that extensive research had established no connection between vaccines and autism.

As part of its updated stance, the CDC indicated that the header “Vaccines do not cause autism” remains on the page, but it now includes an asterisk. This asterisk clarifies that the statement was retained due to a prior agreement rather than because of supporting evidence.

The Children’s Health Defense, an organization that has long questioned the safety of vaccines, praised the CDC’s updated position. Mary Holland, president and CEO of the organization, expressed optimism about the change. “Finally, the CDC is beginning to acknowledge the truth about this condition that affects millions, disavowing the bold, long-running lie that ‘vaccines do not cause autism,’” she told Fox News Digital.

Holland emphasized that no studies have definitively proven the claim that vaccines do not contribute to autism. She pointed out that many studies suggest vaccines could be a plausible primary cause of the condition. The HHS’s comprehensive assessment is expected to include investigations into plausible biological mechanisms and potential causal links related to autism.

In contrast, other medical organizations have firmly rejected the notion that vaccines contribute to autism. The American Academy of Pediatrics maintains on its website that “studies have repeatedly found no credible link between life-saving childhood vaccines and autism.” They further state that while research continues to uncover potential causes of autism, vaccines are not among them, and there is no single root cause of the disorder.

Current CDC data indicates a rising trend in autism diagnoses among children. For instance, among children aged 8 years born in 2014, approximately one in 31 (3.2%) were identified with autism spectrum disorder, a significant increase from one in 150 (0.67%) in the year 2000.

Fox News Digital reached out to healthcare professionals and the HHS for additional comments regarding the updated stance.

Source: Original article

Novo Nordisk Reaches Agreement with U.S. on Obesity Drug Pricing

Novo Nordisk has reached an agreement with the U.S. on maximum fair prices for its semaglutide-based drugs, effective January 2027, as part of the Inflation Reduction Act.

Novo Nordisk announced on Wednesday that it has agreed to the U.S. Inflation Reduction Act’s (IRA) negotiated maximum fair prices for semaglutide, the active ingredient in its widely used medications, Ozempic and Wegovy. This agreement will take effect in January 2027.

“While maintaining all legal challenges and rights, Novo Nordisk accepted the U.S. Inflation Reduction Act’s Maximum Fair Price (MFP) for Ozempic, Rybelsus, and Wegovy in Medicare Part D, effective as of January 2027,” the Danish pharmaceutical company stated.

These medications are included in the second batch of 15 drugs selected under President Biden’s 2022 IRA program, which enables Medicare to negotiate prices for some of the most expensive treatments available to seniors and individuals with disabilities.

Novo Nordisk indicated that the estimated direct impact of a semaglutide MFP in Medicare Part D, had it been implemented on January 1, 2025, would have resulted in a negative low single-digit impact on global sales growth for the entire year. The company now anticipates that its sales for 2025 will grow by up to 11% and operating profit by as much as 7% at constant exchange rates. This is a revision from its previous forecast of up to 14% revenue growth and a 10% profit increase.

Headquartered in Bagsværd, Denmark, Novo Nordisk is a prominent global pharmaceutical firm specializing in therapies for diabetes, obesity, cardiovascular conditions, and rare diseases. Its semaglutide-based drugs, including Ozempic for diabetes management and Wegovy for obesity treatment, are crucial to the company’s growth trajectory. However, competition in the U.S. market has intensified, particularly from Eli Lilly and other GLP-1 alternatives.

In the first half of 2025, Novo Nordisk reported approximately 18% sales growth at constant exchange rates, with revenues reaching DKK 154.9 billion and an operating profit of DKK 72.2 billion. Despite this strong performance, the company has faced challenges such as slower U.S. adoption, pricing pressures, and competitive market dynamics, leading it to revise its full-year 2025 guidance to 8–14% sales growth and 10–16% operating profit growth at constant exchange rates. This adjustment reflects a significant slowdown expected in the latter half of the year.

As part of its strategic transformation, Novo Nordisk plans to reduce its global workforce by approximately 9,000 positions, which constitutes about 11% of its total workforce of around 78,400 employees. This move aims to streamline operations and concentrate resources on core metabolic and cardiovascular therapies.

Despite these challenges, Novo Nordisk maintains a robust product portfolio, a strong global presence, and a commitment to ongoing innovation. The company continues to lead in metabolic and obesity care while navigating an increasingly competitive and complex global market.

In summary, Novo Nordisk’s acceptance of the U.S. Inflation Reduction Act’s negotiated maximum fair prices for its semaglutide-based drugs marks a significant development in the pharmaceutical landscape. The company has acknowledged that had these prices been in effect in 2025, global sales growth could have been negatively impacted by a low single-digit percentage, indicating that the projected effects are not yet realized.

Looking ahead, Novo Nordisk faces ongoing challenges, including regulatory changes, pricing pressures, and heightened competition. These factors underscore that while the company’s 2025 results are strong, they reflect a combination of actual performance and anticipated market dynamics, with future growth not guaranteed.

Source: Original article

Study: Exercise Boosts Mood, Mental Health With One Key Condition

Exercise can significantly boost your mood and mental health if done in the right context, according to a new study.

Exercise is widely acknowledged as beneficial for physical health, but its impact on mental well-being depends heavily on the context in which it is performed. A new study published in Medicine & Science in Sports & Medicine reveals that the setting, motivations, and manner of exercise crucially influence its mood-enhancing effects.

While engaging in a standard workout routine, like a game involving pushups or a solo walk, promotes cardiovascular health and physical fitness, the emotional benefits may vary. For example, challenging oneself to complete a deck-of-cards pushup routine presents a physical challenge with a sense of accomplishment. However, the mood-lifting perks can be amplified through social interaction or a change of scenery.

The study emphasizes that the mental benefits of exercise are not just a matter of duration or intensity. Moderate aerobic exercise is known to improve mood for several hours post-workout, as demonstrated in previous research by the University of Vermont. Yet, this current study highlights that factors such as the exercise environment, social setting, and personal significance attributed to the activity play a substantial role in how one feels afterward.

For instance, a fitness regimen shared with others, such as playing “pushup poker” with a companion or exercising in a more engaging location like a beach, turns the experience into a more enjoyable and mood-boosting activity. Similarly, the mood-enhancing effects of a solitary six-mile walk pale in comparison to the camaraderie experienced during a socially interactive activity such as a round of golf with a family member, even if one’s performance in the game is less than stellar.

Researchers argue that tailoring the context of physical activity to an individual’s preferences and social inclinations can significantly amplify its benefits for mental health. Whether it is lifting weights alone versus in a supportive group, or choosing to exercise outdoors instead of indoors, the psychological gains are contingent upon these experiential facets. Furthermore, the intrinsic motivation behind exercising—whether for health, longevity, or personal satisfactions like improved cognitive skills—further enhances the well-being effects.

In conclusion, while traditional measures of exercise’s benefits focus on frequency, duration, and intensity, these should now be accompanied by thoughtful consideration of the situational aspects encircling the workout. By optimizing these factors, individuals are more likely to gain greater mental health advantages alongside the physical ones.

According to the researchers involved in the study, approaching exercise with an awareness of these contextual factors can lead to more fulfilling and mentally rewarding experiences. As they point out, the right context that aligns with personal values and social preferences is key to unlocking the full mood-boosting potential of physical activity.

Source: Original article

Sreedhareeyam, While Spreading Ayurveda Across the Globe, Continues Its Mission Restoring Vision For All

Sreedhareeyam Ayurvedic Eye Hospital, located strategically in the picturesque town of Koothattukulam, nestled amidst the serene beauty of Kerala’s countryside, was established in the year 1931 by Vaidya Thrivikraman Namboothiri and his brother Vaidya Parameswaran Namboothiri, where Ayurveda Ophthalmology services were provided at their ancestral home of Nelliakattu Mana. It was then known not as Sreedhareeyam, but was called Shridhari Vaidyasala.

Thrivikraman Namboothiri practiced Medicine and Parameswaran Namboothiri would prepare and manufacture the medications, which were in very small quantities for the patients. Often medications were prescribed by the Vaidyas (Doctors), and patients would go to Koothattukulam Vaidyasala or other ayurvedic stores, where they could purchase the 10-20 ingredients and prepare the medications at home.

NPP Namboothiti teaching new DoctorsContinuing these ancient Indian principles and focusing on the assessment and treatment of the eyes, Sreedhareeyam was taken to the next level through the dynamic leadership of Dr. NPP Namboothiri, who was trained under the guidance of Vaidyan Trivikraman Namboodiri and other eminent ophthalmology practitioners in Kerala. After his passing away in 2021, Dr. Narayanan Namboothiri has been entrusted with the role of Medical Director and has been leading this prestigious Eye Hospital to newer heights.

In an exclusive interview with this writer, Dr. Namboothiri, who sees patients in the same house that he was born decades ago, says Ayurveda places a strong emphasis on the diagnosis of the disease. And those who practice Ayurveda use three tools: seeing, touching and assessing, and often do not use any instruments for the diagnosis of one’s illness. For Vata, Pitta, and Kapha disorders, the doctor would carefully monitor the patient’s pulse at the onset and diagnose the illness.

The ancient Indian classicals have described the ways to diagnose the severity of one’s illness by placing the fingers on the wrist area, and a physician can measure through the “Nadi Pariksha” that is pulse reading and one is able to assess and evaluate a person’s body, mind, soul, and spirit. Thus, Nadi Pariksha serves as a critical tool for diagnosis, prognosis, and determination of the Physiological and Pathological State of the Patient’s Body through the Science of Nadi Vigyan.

Sreedhareeyam Day Begins with Prayer at NaalukettuAs per Dr. Namboothiri, there are about 40 to 45 Doctors in addition to hundreds of supporting staff here working at Sreedhareeyam and its branches across India and abroad, who are led and trained by some senior Doctors, who are also assisting in the treatment of patients here and other branches.

Dr. Narayanan Namboothiri, who used to personally meet and treat every patient who visited the hospital during the initial years, gives credit to the “dedication and commitment” of the staff for the success and growth of Sreedhareeyam. “Even though I cannot see everyone, the Senior Doctors, whom I had the privilege of training are now able to train other Doctors and every one of them helps realize the mission of Sreedhareeyam.”

Unlike in the past, where fresh medical ingredients were prepared by hand, now Sreedhareeyam boasts of its highly advanced medicines factory that prepares and manufactures medicines in large quantities that meets the growing demands for the thousands of its own patients and supplying them to several other hospitals.

Sreedhareeyam, in its mission to share the ancient knowledge in Ayurveda has its Research Wing that closely monitors and documents the impact of the treatment for other facilities and future generations to emulate from its own success stories of the thousands of patients who benefit from the treatment.

“Led by a team of Doctors, our Research Team has published scientific articles in renowned research journals which is an effective way of sharing ancient knowledge and wisdom and its impact on current population, Dr. Namboothiri says. “When people read and hear about these concrete and evidence-based success stories, they come to Sreedhareeyam,” states Dr. Namboothiri, who does not believe in paid marketing campaigns to promote Sreedhareeyam and its impact on restoring vision to people.

Sreedhareeyam NethradharaAmong the thousands of successful cases, Dr. Narayanan recalls how Sreedhareeyam could help restore the vision for Rose Mary Odinga, the daughter of Raila Odinga, former Prime Minister of Kenya in 2023. After being diagnosed with a brain tumor in 2017, Odinga’s daughter had undergone surgery in Nairobi. But in the post-operative period, Rosemary had complained of severe loss of eyesight. She travelled to India in 2019 and underwent treatment at Sreedhareeyam, which helped her vision to restore.

Rose Mary said, in 2018, she suffered from aneurysm, and subsequently her eyesight became weak. For treatment, she went to Germany, Japan and South Africa. “I also went to China two times, where I received treatment using acupuncture,” she said. Having not received much success, Rosemary Odinga finally came to India, where she underwent treatment at Sreedhareeyam, where she was treated in two sessions of three weeks each.

Dr. Namboothiri says, “When she came to us two years ago, she was totally blind with some light perception with no clear visibility. She came after having undergone several treatments in other countries. She had suffered loss of eyesight due to aneurysm and atrophy in the optic nerve.”

Rose Mary received Ayurvedic treatment, involving oral medication as well as rejuvenation therapy of the nervous system, “After the first session itself she showed signs of improvement,” he said. “When she first came, she was only left with some perception of light, and her field of vision was completely lost. Now, she is moving around,” Dr Namboothiri added. Rosemary said she was happy and excited to finally see Dr. Namboothiri clearly. “(When I first met him), I could not see him, I could just hear his voice…follow his instructions. But now I can see him,” she said.

“I guess it is a testimony that AYUSH has helped someone else, other than India, from another part of the world. It is a testimony that it is universal, that solutions of AYUSH are universal, and I am proud to be part of this story,” said Rosemary Odinga. AYUSH’ denotes Ayurveda, Yoga, Naturopathy, Unani, Siddha and Homoeopathy. India has a federal ministry dedicated to these alternative medicine systems.
Mr. Odinga was all praise for the medical services rendered by the Sreedhareeyam, helping his daughter regain her eyesight.
India’s Prime Minister Narendra Modi, during his weekly “Man Ki Bhaat” mentioned Rosemary Odinga’s story and, while no medical treatment was helping her regain eyesight, Sreedhareeyam helped her. “She was treated in many countries but did not regain her eyesight. At last, she found success in India, that too after Ayurveda treatment. Rosemary’s eyesight returned, and she can see now. Her father told me that when she saw her children for the first time after the treatment, it was a golden moment of her life,” Modi said.

Sreedhareeyam While Spreading Ayurveda Across the GlobeSimilar stories by people from abroad and in India are not uncommon. Ralitsa Dutch, a 37-year-old patient from the Netherlands shared about her experience at Sreedhareeyam and Ayurveda this way: “I experienced optic neuritis, an inflammation of the optic nerve in relation to a Multiple Sclerosis (MS) relapse. Since then, my right eye has been heavily impaired. In 2013, when allopathic medicine deemed my case as “hopeless,” I started looking at alternative treatments and got to know about Ayurveda. The decision to come to India and undergo Ayurvedic treatment turned out to be life changing. After a three month stay at a specialized Ayurvedic MS center, my right eye “woke up” for the first time. After three consecutive stays, my MS stabilized, and I have not had any relapses ever since.”

Ralitsa went on to state that even though her MS stabilized, her vision did not come back to normal. It was in early 2023 “when I got to know about Sreedhareeyam, where I stayed for a two-week treatment. A year later, the test results showed improvement in the thickness of both the eye nerve and retina, indicating that 1) despite the 10-year gap, the nerve and retina are capable of regenerating and 2) there is a possibility of further regeneration followed by improvements of my eyesight. And I believe, Ayurveda is a synonym of hope and I encourage anyone who feels hopeless to give it a try.”

Dr. Namboothiri says, many come to Sreedhareeyam as the last resort, where all other options, including most modern medicines have failed them. According to him, in modern allopathic medicine, for each disease there may be multiple medications prescribed, with several side effects. However, in Ayurveda, such concept is not there. But, in ayurveda, Doctors prescribe medications that target holistically, and are treating the basic cause for any disease.

On the connection between vegetarian food and ayurvedic medicine, Dr. Namboothiri says, “Food is at the center of the medicines we give to our patients. And it’s preferred that we eat food that is easily digestible. In addition, vegetables contain lots of ingredients, including vitamins and the minerals our bodies need. Carbohydrates and protein, which are non-vegetarian items won’t digest easily, and will add to the increase of fat in our body, which contributes to collapsing of the circulation of blood. Whenever the blood is not flowing and its pathway is getting obstructed, that leads to problems in the brain, and to the upper limbs or lower limbs everywhere. It is very difficult to treat a patient with obesity and is a major challenge.”

Regarding the growing interest now in Ayurveda his thoughts for the upcoming Doctors and medical students who want to be “Another Dr. Narayanan,” Dr. Namboothiri says, people coming from outside of Kerala are not getting sufficient exposure in other ayurveda systems and its ways of treatment. Here in Kerala, there are several Ayurvedic hospitals, where thousands of patients are being treated and medical students have direct knowledge and exposure. “My suggestion to those doctors is that it is important to practice medicine with a very good understanding of Ayurveda, so that they can provide good relief to the patients with the Ayurvedic system of medicines. For instance, if someone has a fever, one should know that it can be resolved even with the one day of fasting itself. Follow the Panchakarma procedure with which they can do wonders,” he added.

Dr. Namboothiri gives credit to “My Gurus in Ayurveda, my uncle NPP Namboothiri, and Dr. B Vaidyanadhan who was in Chennai and was a famous ayurvedic doctor, with whom I had the privilege of working with for about a year. But quite often I used to go to him and learn from his approaches. He used to examine patients using the nadi parikshanam. He used to give only limited medicines, which are pinpointed and treat the ailments in his patients. I learnt a lot from him and his approach to treating patients.”

Entrance to Nellikattu Bhagwathy Temple where the Lamps are lit and burn 247 all daytsDr. Namboothiri thanked the Modi government in India, saying “It is very helpful that the Modi Government promotes Ayurveda. The government is doing many things, and he is a very good ambassador for Ayurveda as well as Yoga. An All-India Institute of Ayurveda has been started in Delhi with centers in Gujarat and Goa. The creation of Ayush Ministry is a big boost for the ancient medical traditions of Inda.”

While describing the secret to the success and growth of Sreedhareeyam, especially in the past quarter century, Dr. Namboothiri says, “I am grateful to the Divine power of the Bhagavathi, who is in front of the hospital and the divine power of Mahadeva, who is behind the hospital.”

The treatment for every patient at Sreedhareeyam begins with praying and offerings to the Divine. The staff here gather before the Bhagavathi every morning at the “Naalukattu” where the hospital originated, seeking her blessings on every patient and staff. Dr. Narayanan says, “It’s the Prakasam, that is the lighting of the lamp all night and day before the Divine” that helps sustain the vision for all of our patients.” In addition, he says, “It’s not only that I feel the power of the Divine while entering the Hospital, but there are others who feel and share the same,” which is the secret to the success of the mission of Sreedhareeyam, which is “restoring the vision for all.”

Sreedhareeyam’s commitment to the fusion of traditional Ayurveda with modern technology results in effective, safe, and reliable treatments for eye ailments. Sreedhareeyam has expanded and grown tremendously in its headquarters at Koothatukulam and having opened several new centers across many states in India and abroad. New sections are being constructed at Sreedhareeyam and there plans to open new centers in other states across India and abroad.

When asked about the future of Sreedhareeyam, Dr. Namboothiri says, “At Sreedhareeyam, our major objective is that every patient should receive maximum benefit from the treatment we provide. We are not looking at having more patents each day, but we want to provide quality care to all those who come here seeking treatment.”

Global Life Expectancy to Rise by 2050, But More Years in Poor Health Expected, Study Reveals

A study released on Friday predicts a significant rise in global life expectancy by 2050, despite current geopolitical, metabolic, and environmental challenges. The study, derived from the Global Burden of Disease Study (GBD) 2021 and published in The Lancet journal, forecasts an increase of 4.9 years for men and 4.2 years for women.

However, the study also indicates that people will likely spend more of these additional years in poor health. This is primarily due to a shift from communicable, maternal, neonatal, and nutritional diseases (CMNNs) to non-communicable diseases (NCDs) such as cardiovascular diseases, cancer, chronic obstructive pulmonary disease, and diabetes.

According to the research, global life expectancy is expected to rise to 78.1 years by 2050, representing a 4.5-year increase from current figures. Additionally, global healthy life expectancy (HALE) — the average number of years a person can expect to live in good health — is projected to increase to 67.4 years by 2050, an improvement of 2.6 years.

“In addition to an increase in life expectancy overall, we have found that the disparity in life expectancy across geographies will lessen,” said Chris Murray, Chair of Health Metrics Sciences at the University of Washington and Director of the Institute for Health Metrics and Evaluation (IHME).

Murray emphasized that the most significant opportunity to reduce the global disease burden lies in policy interventions aimed at preventing and mitigating behavioral and metabolic risk factors. “There is immense opportunity ahead for us to influence the future of global health by getting ahead of these rising metabolic and dietary risk factors, particularly those related to behavioral and lifestyle factors like high blood sugar, high body mass index, and high blood pressure,” he stated.

The findings underscore the importance of addressing non-communicable diseases, which are poised to become the predominant health challenges globally. The research highlights the need for robust health policies that focus on preventive measures to curb the rise of these conditions.

The shift from communicable diseases to non-communicable diseases marks a significant transition in global health trends. While advancements in medical science and public health have led to a decline in communicable diseases, the increasing prevalence of NCDs presents new challenges. These diseases are often linked to lifestyle factors such as poor diet, lack of physical activity, and exposure to tobacco and alcohol.

This trend underscores the necessity for comprehensive health strategies that encompass preventive care, early detection, and management of NCDs. Policymakers and health professionals must prioritize interventions that target these risk factors to improve health outcomes and reduce the disease burden.

The anticipated rise in life expectancy and healthy life expectancy indicates progress in global health but also highlights the need for sustained efforts to address health disparities. The reduction in geographical disparities in life expectancy suggests that more regions will experience improvements in health outcomes, but it also calls for targeted efforts to support areas that lag behind.

Murray’s call for policy interventions reflects a broader consensus among health experts on the importance of addressing behavioral and metabolic risk factors. Effective policies can lead to significant health improvements and contribute to the overall well-being of populations.

The study’s projections serve as a reminder of the ongoing challenges in global health and the critical role of preventive measures in addressing these challenges. As the global population continues to grow and age, the burden of non-communicable diseases is expected to increase, necessitating proactive and comprehensive health strategies.

While the projected increase in global life expectancy by 2050 is a positive development, it comes with the caveat that people will spend more years in poor health due to the rise of non-communicable diseases. Addressing these diseases through effective policy interventions targeting behavioral and metabolic risk factors is essential for improving global health outcomes. The study highlights the need for a concerted effort to tackle the emerging health challenges and ensure that the gains in life expectancy translate into better quality of life for all.

-+=